FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection

FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection

<p>Abstract</p> <p>Background</p> <p>Herpes simplex virus type 2 (HSV-2) is a leading cause of genital ulceration that can predispose individuals to an increased risk of acquiring other sexually transmitted infections. There are no approved HSV-2 vaccines and current su...

Full description

Bibliographic Details
Main Authors:	Pyles Richard B, McGowin Chris L, Rose William A
Format:	Article
Language:	English
Published:	BMC 2009-11-01
Series:	Virology Journal
Online Access:	http://www.virologyj.com/content/6/1/195

Similar Items

Toll-Like Receptor 9 Agonists in Cancer
by: Karapetyan L, et al.
Published: (2020-10-01)

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
by: Sudeep Kumar, et al.
Published: (2019-05-01)

Natural killer cells responsiveness to Toll-like receptor agonists during bacterial sepsis
by: Souza Fonseca Guimaraes, Fernando de
Published: (2012)

FSL-RFG(Maleimide) FSL construction kit
by: Henry, SM, et al.
Published: (2011)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
by: Max E. Kirtland, et al.
Published: (2020-11-01)

Toll-Like Receptor 9 Agonists for Cancer Therapy
by: Davide Melisi, et al.
Published: (2014-08-01)

Toll like receptors agonists-based nanomedicines as veterinary immunotherapies
by: Eder L Romero, et al.

Trial Watch: Toll-like receptor agonists in cancer immunotherapy
by: Melody Smith, et al.
Published: (2018-12-01)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
by: Huju Chi, et al.
Published: (2017-05-01)

The toll-like receptor agonist imiquimod is active against prions.
by: Nassima Oumata, et al.
Published: (2013-01-01)

Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists
by: Fabiana Evaristo-Mendonça, et al.
Published: (2019-01-01)

Extracellular Ribosomal RNA Acts Synergistically with Toll-like Receptor 2 Agonists to Promote Inflammation
by: Bauer, S., et al.
Published: (2022)

Effects of Toll-like receptor agonists on the pathogenesis of atopic asthma in mice
by: Düchs, Matthias
Published: (2011)

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
by: Janne Tegder Martinsen, et al.
Published: (2020-06-01)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
by: Amanda B. Macedo, et al.
Published: (2019-10-01)

Mechanisms of airway smooth muscle activation by agonists of toll-like receptors
by: Morris, Gavin Edward
Published: (2005)

The Toll-like receptor 7 agonist imiquimod increases ethanol self-administration and induces expression of Toll-like receptor related genes
by: Besheer, J., et al.
Published: (2022)

Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants
by: Dennis Hanzelmann, et al.
Published: (2016-07-01)

Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2).
by: Alexander N Shakhov, et al.
Published: (2012-01-01)

Anti-tumor Effects and Antigen Presentation Mechanisms of Toll-like Receptor 2 (TLR2) agonist-conjugated peptide
by: Kuan-Yin Shen, et al.
Published: (2014)

EXPRESSION FEATURES OF TOLL-LIKE RECEPTOR 2 AND TOLL-LIKE RECEPTOR 4 IN CHILDREN WITH ASTHMA
by: L. V. Gankovskaya, et al.
Published: (2017-08-01)

PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: A. A. Nikonova, et al.
Published: (2019-07-01)

PROSPECTS OF TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: Alexandra Alexandrovna Nikonova, et al.
Published: (2019-03-01)

Toll-Like Receptor Agonists Modulate Wound Regeneration in Airway Epithelial Cells
by: Anna Lewandowska-Polak, et al.
Published: (2018-08-01)

Effects of Toll-like receptor agonists on porcine peripheral blood mononuclear cells
by: Lai Yi-Chen, et al.
Published: (2012)

A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.
by: Nicholas D Leigh, et al.
Published: (2014-01-01)

Subverting Toll-like receptor signalling by bacterial pathogens
by: Victoria eMcGuire, et al.
Published: (2015-12-01)

Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists
by: Christian Behm, et al.
Published: (2019-01-01)

Intracellular <it>Mycoplasma genitalium </it>infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing
by: Pyles Richard B, et al.
Published: (2009-07-01)

GSP-2, a polysaccharide extracted from Ganoderma sinense, is a novel toll-like receptor 4 agonist.
by: Kai-Sheng Liu, et al.
Published: (2019-01-01)

Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17.
by: Christopher Paustian, et al.
Published: (2013-01-01)

CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent
by: A. Macedo, et al.
Published: (2015-12-01)

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
by: Kai Naumann, et al.
Published: (2013-01-01)

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
by: Catherine Gurley, et al.
Published: (2008-01-01)

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications
by: Vadim Mett, et al.
Published: (2021-04-01)

Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr mice.
by: Simon J Freeley, et al.
Published: (2013-01-01)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
by: Nathalie Guriec, et al.
Published: (2018-11-01)

Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer
by: Mira A Lanki, et al.
Published: (2018-09-01)

The Toll-Like Receptor 2 agonist PEG-Pam2Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites
by: Medard Ernest, et al.
Published: (2018-12-01)

Activation of Innate Immunity by Bacterial Ligands of Toll-like Receptors
by: Nelli K. Akhmatova, et al.
Published: (2014-03-01)

Cannot write session to /tmp/vufind_sessions/sess_r4tu1d8fhnr0kkbdihj48b2ubj